High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition.
1/5 보강
High-throughput proteomic profiling provides a comprehensive analysis of systemic cancer effects and tumor microenvironment interactions.
APA
Garcia MB, Wang B, et al. (2026). High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition.. Molecular & cellular proteomics : MCP, 25(3), 101522. https://doi.org/10.1016/j.mcpro.2026.101522
MLA
Garcia MB, et al.. "High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition.." Molecular & cellular proteomics : MCP, vol. 25, no. 3, 2026, pp. 101522.
PMID
41621809 ↗
Abstract 한글 요약
High-throughput proteomic profiling provides a comprehensive analysis of systemic cancer effects and tumor microenvironment interactions. Characterizing soluble proteins driving inflammation in acute myeloid leukemia (AML) offers insight into inflammatory diseases like differentiation syndrome related to AML therapies like menin inhibitors. We present our application of nucleic acid-linked immuno-sandwich assay, a novel technology leveraging next-generation sequencing for high-throughput, ultrasensitive characterization of secreted inflammatory proteins in plasma or serum. Here, we report its use to identify dynamic soluble protein changes during treatment and at the time of suspected differentiation syndrome in pediatric AML patients treated with the menin inhibitor revumenib (NCT04065399 and NCT05360160).
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.